Investment
Features
FeesSafety
Academy
More
Pluang+

Osisko Gold rated 'Buy' on strong financing and clear two-year build plan for Cariboo project.

Market News
07 Oct 2026
Seeking Alpha
View Source
Bullish
Osisko Gold rated 'Buy' on strong financing and clear two-year build plan for Cariboo project.

Osisko Gold Group is rated 'Buy' due to its recent $600 million note financing that secures funding through the first gold pour at its Cariboo project. The flagship Cariboo mine aims to produce 220,000 ounces of gold annually for five years with a strong internal rate of return between 22.1% and 53.8% and an all-in sustaining cost of $1,157 per ounce. The company trades at a 40%-50% discount to net asset value, reflecting construction risks, but significant upside is expected as key milestones approach. This financing and clear two-year construction timeline reduce risk and position Osisko Gold for medium-term value growth.

Osisko Gold Group is the story subject, with Pluang market data providing context. For readers following Basic Materials stocks, here is Pluang's market snapshot as of Oct 07, 2026 18:12 WIB: Out of 38 priced US stocks, 6 rose and 30 fell. Kinross Gold Corporation (KGC) traded at USD 23.40 with a 1-day change of -1.72% and 100% buy order activity. Newmont Corporation (NEM) was at USD 114.39, down 1.72%, with a near-even buy/sell split. MP Materials (MP) closed at USD 47.72, down 1.67%, with 67% buy orders and a typical hold time of 10 days.

More News

Ironwood Pharmaceuticals' future hinges on apraglutide amid generic threats to Linzess by 2029.

Ironwood Pharmaceuticals' future hinges on apraglutide amid generic threats to Linzess by 2029.

Ironwood Pharmaceuticals is rated Buy mainly due to its drug apraglutide, as its current cash flow from Linzess faces pressure from upcoming generic competition expected by 2029 and Medicare price cuts. Linzess revenues are largely committed to debt ...

Analyst Insights
Bullish
4 hours ago
Lumentum posts record $1.01B Q4 revenue, shares surge 207% in 2026 on strong institutional buying.

Lumentum posts record $1.01B Q4 revenue, shares surge 207% in 2026 on strong institutional buying.

Lumentum, a maker of optical and photonic products, reported a record $1.01 billion revenue in Q4 fiscal 2026, up 109% year-over-year, with non-GAAP net income rising 267% to $326.3 million. The company also provided strong guidance for Q1 2027, expe...

Company Fundamentals
Bullish
4 hours ago
Canary XRP ETF drops 36.68% since Nov 2025, holding $372.9M in assets as of Sept 2026

Canary XRP ETF drops 36.68% since Nov 2025, holding $372.9M in assets as of Sept 2026

Canary Capital's Canary XRP ETF (XRPC) has fallen 36.68% since its launch in November 2025, trading at $15.74 with a net asset value of $15.83 as of September 28, 2026. Despite the decline, the fund holds $372.9 million in net assets and charges a 0....

Market News
Bearish
4 hours ago
Pi Network advances Protocol 28 to Testnet, plans Mainnet launch on Oct 16 with node upgrade deadline Oct 13

Pi Network advances Protocol 28 to Testnet, plans Mainnet launch on Oct 16 with node upgrade deadline Oct 13

Pi Network has moved its Protocol 28 upgrade to the Testnet stage and scheduled the Mainnet rollout for October 16. Node operators are required to upgrade their software by October 13 to support the new protocol, which aims to reduce transaction dela...

Protocol Fundamentals
Neutral
4 hours ago
HBAR nears $0.09 support level amid market analysis but recent data shows it closed above $0.10.

HBAR nears $0.09 support level amid market analysis but recent data shows it closed above $0.10.

HBAR, the native cryptocurrency of Hedera, was analyzed to be near a support level of $0.09 on October 7. However, historical trading data from October 6 shows the token closed at $0.1012, with a low of $0.1010 and a high of $0.1021, indicating no co...

Technical Signals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App